Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine dose-escalation study in acquired cold urticaria
2008-005746-22Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desloratadine in Cold urticaria (CU) and chronic urticaria (CU) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Assessment of wheal development before and after treatment. Started Jan 2009; status: completed.
02
Drugs
desloratadine
03
Conditions
Cold urticaria (CU)chronic urticaria (CU)
Beyond the preview
Go deeper on 2008-005746-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005746-22.